The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors

NCT00001189 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
150
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Cancer Institute (NCI)